Filing Details
- Accession Number:
- 0001209191-15-064625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-07 16:13:22
- Reporting Period:
- 2015-08-05
- Filing Date:
- 2015-08-07
- Accepted Time:
- 2015-08-07 16:13:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438133 | Tandem Diabetes Care Inc | TNDM | Surgical & Medical Instruments & Apparatus (3841) | 204327508 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365369 | F John Sheridan | C/O Tandem Diabetes Care, Inc., 11045 Roselle Street San Diego CA 92121 | Evp & Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-05 | 17,500 | $1.11 | 21,584 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-05 | 17,500 | $12.70 | 4,084 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-08-06 | 17,500 | $1.11 | 21,584 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-06 | 17,500 | $12.19 | 4,084 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2015-08-05 | 17,500 | $0.00 | 17,500 | $1.11 |
| Common Stock | Stock Options | Disposition | 2015-08-06 | 17,500 | $0.00 | 17,500 | $1.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 137,540 | 2014-02-25 | 2023-04-23 | No | 4 | M | Direct |
| 120,040 | 2014-02-25 | 2023-04-23 | No | 4 | M | Direct |
Footnotes
- The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $12.50 to $13.05. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $12.08 to $12.50. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The option became 25% exercisable on 2/25/2014 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
